Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

YONEKURA, Hideto, YAMAMOTO, Yasuhiko, SAKURAI, Shigeru, PETROVA, Ralica G., ABEDIN, Md. Joynal, LI, Hui, YASUI, Kiyoshi, TAKEUCHI, Masayoshi +5 more·2003·Biochemical Journal
DOI 10.1042/bj20021371

Cited by (712)

Items 201–300 of 712

  1. Soluble receptor for advanced glycation end products and risk of liver cancer
    Kristin A. Moy, Li Jiao, Neal D. Freedman, Stephanie J. Weinstein, Rashmi R. Sinha, Jarmo R. K. Virtamo, Demetrius Albanes, Rachael Z. Stolzenberg‐Solomon · 2013 · Hepatology
  2. Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness
    Kyung Mook Choi, Hye Jin Yoo, H.Y. Kim, K. W. Lee, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Dong Seop Choi, Sei Hyun Baik · 2008 · International Journal of Cardiology
  3. Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells
    Naoko Yamakawa, Tokujiro Uchida, Michael A. Matthay, Koshi Makita · 2011 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  4. Resveratrol, Wine, and Atherosclerosis
    Kailash Prasad · 2012 · International Journal of Angiology
  5. Regulation of RAGE for Attenuating Progression of Diabetic Vascular Complications
    Myat Thu Thu Win, Yasuhiko Yamamoto, Seiichi Munesue, Hidehito Saito, Dong Gwan Han, So Motoyoshi, Tarek Kamal, Takuro Ohara, Takuo Watanabe, Hiroshi Yamamoto · 2011 · Experimental Diabetes Research
  6. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression
    Ai Harashima, Yasuhiko Yamamoto, Chunmei Cheng, Koichi Tsuneyama, Khin Mar Myint, Akihiko Takeuchi, Kazunobu Yoshimura, Hui Li, Takuo Watanabe, Shin Takasawa et al. · 2006 · Biochemical Journal
  7. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation
    Roberto J. Romero, Jimmy Espinoza, Sonia S. Hassan, Francesca Gotsch, Juan Pedro Kusanovic, Cecilia Avila, Offer Erez, Samuel S. Edwin, Ann Marie Schmidt · 2008 · Journal of Perinatal Medicine
  8. Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress
    Jingdong Qin, Rajendra Goswami, Sylvia Dawson, Glyn Dawson · 2008 · Journal of Neuroscience Research
  9. Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors
    Singh, Harbinder, Agrawal, Devendra K. · 2022 · Drug Development Research
  10. The immunobiology of the receptor of advanced glycation end-products: Trends and challenges
    Ileana González, Jacqueline A. Romero, Boris Luis Rodríguez, Ramón Pérez-Castro, Armando Rojas R · 2012 · Immunobiology
  11. Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function
    Joel Jules, Dony A. Maiguel, Barry Ian Hudson · 2013 · PLoS ONE
  12. Diabetes and Vascular Disease: Basic Concepts of Nitric Oxide Physiology, Endothelial Dysfunction, Oxidative Stress and Therapeutic Possibilities
    Verena Kise Capellini, Andréa Carla Celotto, Caroline Floreoto Baldo, Vânia Cláudia Olivon, Fernanda Viaro, Alfredo José Rodrigues, Paulo Roberto Barbosa Évora · 2010 · Current Vascular Pharmacology
  13. Role of NF-κB in Platelet Function
    Kevin Kojok, Abed El-Hakim El-Kadiry, Yahye Merhi · 2019 · International Journal of Molecular Sciences
  14. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts
    Hans L. A. Nienhuis, Karina de Leeuw, Johannes Bijzet, Andries Jan Smit, Caspar Schalkwijk, R. Graaff, Cees G. M. Kallenberg, Marc Bijl · 2008 · Lara D. Veeken
  15. Advanced Glycation End Products: key player of the pathogenesis of atherosclerosis
    Sanjiv Singh, Boddu Veerabadra Siva, V. Ravichandiran · 2022 · Glycoconjugate Journal
  16. Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
    Harbinder Singh, Devendra K. Agrawal · 2022 · Molecules
  17. Human Apo-Lactoferrin Enhances Angiogenesis Mediated by Vascular Endothelial Growth Factor A in vivo
    Klas Norrby · 2004 · Journal of Vascular Research
  18. The G82S Polymorphism Promotes Glycosylation of the Receptor for Advanced Glycation End Products (RAGE) at Asparagine 81
    Sun Jin Park, Torsten Kleffmann, Paul A. Hessian · 2011 · Journal of Biological Chemistry
  19. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity
    J. Brix, Florian Höllerl, H Kopp, Gerit-Holger Schernthaner, Gerit-Holger Schernthaner · 2012 · International Journal of Obesity
  20. Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction
    Delminda Neves · 2013 · Free Radical Research
  21. V domain of RAGE interacts with AGEs on prostate carcinoma cells
    Edith Uetz‐von Allmen, Michael Koch, Günter Fritz, Daniel F. Legler · 2008 · The Prostate
  22. Mechanism of Hypercholesterolemia-Induced Atherosclerosis
    Kailash Prasad, Manish Mishra · 2022 · Reviews in Cardiovascular Medicine
  23. Receptor for Advanced Glycation end Products: Its Role in Alzheimer‘s Disease and other Neurological Diseases
    Lih‐Fen Lue, Douglas G. Walker, Sandra A. Jacobson, Marwan Noel Sabbagh · 2009 · Future Neurology
  24. Soluble RAGE-Modulating Drugs: State-of-the-Art and Future Perspectives for Targeting Vascular Inflammation
    Niccolò Lanati, Enzo Emanuele, Natascia Brondino, Diego Geroldi · 2010 · Current Vascular Pharmacology
  25. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus
    Kateřina Kaňková, Andrea Stejskalová, Miluše Hertlová, Vladimı́r Znojil · 2005 · Nephrology Dialysis Transplantation
  26. HbA1c Identifies Subjects With Prediabetes and Subclinical Left Ventricular Diastolic Dysfunction
    Antonino Di Pino, Sarah Mangiafico, Francesca Urbano, Roberto Scicali, Salvatore Scandura, Veronica D’Agate, Salvatore Piro, Corrado Tamburino, Francesco Purrello, Agata Maria Rabuazzo · 2017 · The Journal of Clinical Endocrinology & Metabolism
  27. RAGE and its emerging role in the pathogenesis of Parkinson’s disease
    Xiuli Jiang, Xiaoli Wang, Miao Tuo, Jiangnan Ma, Anmu Xie · 2018 · Neuroscience Letters
  28. AGE and their receptor RAGE in systemic autoimmune diseases: An inflammation propagating factor contributing to accelerated atherosclerosis
    Hans L. A. Nienhuis, Johanna Westra, Andries Jan Smit, Pieter C. Limburg, Cees G. M. Kallenberg, Marc Bijl · 2009 · Autoimmunity
  29. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
    Steffen Ohlmeier, Witold Mazur, Kaisa Salmenkivi, Marjukka Myllärniemi, Ulrich Bergmann, Vuokko L. Kinnula · 2010 · PROTEOMICS - CLINICAL APPLICATIONS
  30. Glycation Stress and Photo-Aging in Skin
    Masamitsu Ichihashi, Masayuki Yagi, Keitaro Nomoto, Yoshikazu Yonei · 2011 · Anti-aging Medicine
  31. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study
    Sazan Rasul, Marie Helene Schernthaner-Reiter, Ayşegül İlhan, Katharina Lampichler, Ludwig Wagner, Alexandra Kautzky‐Willer · 2011 · Cardiovascular Diabetology
  32. Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
    Francesco Scavello, Filippo Zeni, Calogero C. Tedesco, Emanuela Mensa’, Fabrizio Veglia, Antonio Domenico Procopio, Anna Rita Bonfigli, Fabiola Olivieri, Angela Raucci · 2019 · Aging
  33. AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD?
    Hidenori Koyama, Yoshiki Nishizawà · 2010 · European Journal of Clinical Investigation
  34. Significance of Advanced Glycation End Products in Aging-Related Disease
    Ryoji Nagai, Takefumi Mori, Yasuhiko Yamamoto, Yuichi Kaji, Yoshikazu Yonei · 2010 · Anti-aging Medicine
  35. Methodological and preanalytical evaluation of a RAGE immunoassay.
    Julia Lehner, Christin Wittwer, Debora M.I. Fersching, Barbara Siegele, Stefan Holdenrieder, Oliver J. Stoetzer · 2012 · PubMed
  36. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases
    Masayoshi Takeuchi · 2016 · Diagnostics
  37. Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients
    Erick McNair, Calvin Wells, A Qureshi, Rashpal Basran, Colin Pearce, Jason Orvold, Jacobus Devilliers, Kailash Prasad · 2009 · International Journal of Angiology
  38. The axis of the receptor for advanced glycation endproducts in asthma and allergic airway disease
    Timothy N. Perkins, Mason L. Donnell, Tim D. Oury · 2020 · Allergy
  39. Advanced Glycation End Products in Infant Formulas Do Not Contribute to Insulin Resistance Associated with Their Consumption
    Kristína Simon Klenovics, Peter Boor, Veronika Somoza, Peter Celec, Vincenzo Fogliano, Katarı́na Šebeková · 2013 · PLoS ONE
  40. What is the role of the receptor for advanced glycation end products–ligand axis in liver injury?
    Giuseppina Basta, Teresa Navarra, Paolo DE SIMONE, Serena Del Turco, Amalia Gastaldelli, Franco Filipponi · 2011 · Liver Transplantation
  41. Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy
    Mohsen Kerkeni, Amel Saïdi, Hassan Bouzidi, Slim Ben Yahya, Mohamed Hammami · 2012 · Microvascular Research
  42. Serum S100A12 May Be a Useful Biomarker of Disease Activity in Adult-onset Still’s Disease
    Chang-Bum Bae, Chang‐Hee Suh, Jeong-Mi An, Ju‐Yang Jung, Ja‐Young Jeon, Jinyoung Nam, Hyoun‐Ah Kim · 2014 · The Journal of Rheumatology
  43. Plasma sRAGE Is Independently Associated With Urinary Albumin Excretion in Type 2 Diabetes
    Per M. Humpert, Stefan Kopf, Zdenka Djuric, Thoralf Wendt, Michael Morcos, Peter P. Nawroth, Angelika Bierhaus · 2006 · Diabetes Care
  44. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes
    Antonino Di Pino, Francesca Urbano, Rose Maria Zagami, Agnese Filippello, Stefania Di Mauro, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo · 2016 · The Journal of Clinical Endocrinology & Metabolism
  45. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage
    Masayoshi Takeuchi, Akiko Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama, Chigusa Kikuchi, Ayako Furukawa, Kentaro Nagamine, Takamitsu Hori, Tamihide Matsunaga · 2021 · Biomolecules
  46. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function
    Tomohito Gohda, Mitsuo Tanimoto, Ju-Young Moon, Hiromichi Gotoh, Tatsuya Aoki, Masakazu Matsumoto, Terumi Shibata, Isao Ohsawa, Kazuhiko Funabïki, Yasuhiko Tomino · 2008 · Diabetes Research and Clinical Practice
  47. High Mobility Group Box 1 (HMGB1): Molecular Signaling and Potential Therapeutic Strategies
    Sayantap Datta, Mohammad Atiqur Rahman, Saisudha Koka, Krishna Murthy Boini · 2024 · Cells
  48. Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects
    Antonino Di Pino, Walter Currenti, Francesca Urbano, Concetta Mantegna, Giacomo Purrazzo, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo · 2016 · Journal of clinical lipidology
  49. Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
    Martin Heier, Hanna Dis Margeirsdottir, Mario Gaarder, Knut Haakon Stensæth, Cathrine Brunborg, Peter Abusdal Torjesen, Ingebjørg Seljeflot, Kristian Folkvord Hanssen, Knut Dahl‐Jørgensen · 2015 · Cardiovascular Diabetology
  50. Alterations of circulating endogenous secretory RAGE and S100A9 levels indicating dysfunction of the AGE–RAGE axis in autism
    Marianna Boso, Enzo Emanuele, Piercarlo Minoretti, Mariarosa Arra, Pierluigi Politi, Stefania Ucelli Di Nemi, Francesco Barale · 2006 · Neuroscience Letters
  51. Advanced development and mechanism of sepsis-related acute respiratory distress syndrome
    Huankai Gong, Yao Chen, Meiling Chen, Jiankang Li, Hong Zhang, Shijiao Yan, Chuanzhu Lv · 2022 · Frontiers in Medicine
  52. Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms
    Katharina Anna Sterenczak, Saskia Willenbrock, Matthias Barann, Markus Klemke, Jan T. Soller, Nina Eberle, Ingo J. A. Nolte, Jörn Bullerdiek, Hugo Murua Escobar · 2008 · Gene
  53. Serum albumin induces iNOS expression and NO production in RAW 267.4 macrophages
    Michael Poteser, Ichiro Wakabayashi · 2004 · British Journal of Pharmacology
  54. Low molecular weight heparin suppresses receptor for advanced glycation end products‐mediated expression of malignant phenotype in human fibrosarcoma cells
    Akihiko Takeuchi, Yasuhiko Yamamoto, Seiichi Munesue, Ai Harashima, Takuo Watanabe, Hideto Yonekura, Hiroshi Yamamoto, Hiroyuki Tsuchiya · 2013 · Cancer Science
  55. Possible role of methylglyoxal and glyoxalase in arthritis.
    U. Ahmed, Paul J Thornalley, N. Rabbani · 2014 · Biochemical Society Transactions
  56. Receptor for Advanced Glycation End Products Is a Promising Target of Diabetic Nephropathy
    Yasuhiko Yamamoto, Toshio Doi, Ichiro Kato, Harumichi Shinohara, Shigeru Sakurai, Hideto Yonekura, Takuo Watanabe, KIHN MAR MYINT, Ai Harashima, Masayoshi Takeuchi et al. · 2005 · Annals of the New York Academy of Sciences
  57. Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells
    Yamamoto, Yasuhiko, Yonekura, Hideto, Watanabe, Takuo, Sakurai, Shigeru, Li, Hui, Harashima, Ai, Myint, Khin Mar, Osawa, Mari, Takeuchi, Akihiko, Takeuchi, Masayoshi et al. · 2007 · Diabetes Research and Clinical Practice
  58. Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
    Louise Jung Nørgaard Jensen, Allan Flyvbjerg, Mette Bjerre · 2015 · BioMed Research International
  59. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease
    Kailash Prasad, Indu Dhar, Qifeng Zhou, Hamdi Elmoselhi, Muhammad Shoker, AHMED S. SHOKER · 2016 · Molecular and Cellular Biochemistry
  60. P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation
    Cristina Ana Mocanu, Elena Valeria Fuior, Geanina Voicu, Daniela Rebleanu, Florentina Safciuc, Mariana Deleanu, Ioana Mădălina Fenyo, Virginie Escriou, Ileana Mânduțeanu, Maya Simionescu et al. · 2021 · Journal of Controlled Release
  61. Disulfide Bonds within the C2 Domain of RAGE Play Key Roles in Its Dimerization and Biogenesis
    Wen Wei, Leonie Lampe, Sungha Park, Bhavana S. Vangara, G. S. Waldo, Stéphanie Cabantous, Sarah S. Subaran, Dongmei Yang, Edward G. Lakatta, Lin Li · 2012 · PLoS ONE
  62. Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictor of Restenosis Following Percutaneous Coronary Intervention
    Erick D. McNair, Calvin R. Wells, A. Mabood Qureshi, Rashpal Basran, Colin Pearce, Jason Orvold, Jacobus Devilliers, Kailash Prasad · 2010 · Clinical Cardiology
  63. The Plasma Level of Soluble Receptor for Advanced Glycation End Products is Decreased in Patients with Systemic Lupus Erythematosus
    C.‐Y. Ma, J.‐L. Ma, Y.‐L. Jiao, J.‐F. Li, Li‐Chieh Wang, Q.‐R. Yang, Li You, B. Cui, Zi‐Jiang Chen, Yueran Zhao · 2012 · Scandinavian Journal of Immunology
  64. Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
    Antonio Nenna, Cristiano Spadaccio, Mario Lusini, Luca Ulianich, Massimo Chello, Francesco Nappi · 2016 · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery)
  65. Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis
    Rossana Giulietta Iannitti, Andrea Casagrande, Antonella DE LUCA, Cristina Cunha, Guglielmo Sorci, Francesca Riuzzi, Monica Borghi, Claudia Galosi, Cristina Massi-Benedetti, Tim D. Oury et al. · 2013 · American Journal of Respiratory and Critical Care Medicine
  66. Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
    Anastasia Z. Kalea, Fiona See, Evis Harja, Maria Arriero, Ann Marie Schmidt, Barry Ian Hudson · 2010 · Cancer Research
  67. Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses
    Kaylen Cross, Stefan W. Vetter, Yousuf Alam, Md. Zahidul Hasan, Anupom Deb Nath, Estelle Leclerc · 2024 · Biomolecules
  68. The clinical significance of circulating soluble RAGE in patients with severe sepsis
    Hisatake Matsumoto, Naoya Matsumoto, Hiroshi Ogura, Junya Shimazaki, Kazuma Yamakawa, Kouji Yamamoto, Takeshi Shimazu · 2015 · The Journal of Trauma: Injury, Infection, and Critical Care
  69. Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer’s disease
    Masayoshi Takeuchi, Takashi Sato, Jun-ichi Takino, Yuka Kobayashi, Satomi Furuno, Seiji Kikuchi, Sho‐ichi Yamagishi · 2007 · Medical Hypotheses
  70. Targeting the AGEs-RAGE axis: pathogenic mechanisms and therapeutic interventions in diabetic wound healing
    Haohui Lin, Yi Yang, Xia Wang, Manhon Chung, Li Zhang, Sa Cai, Xiaohua Pan, Yu Chen Pan · 2025 · Frontiers in Medicine
  71. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide
    Nicolas Grossin, Marie‐Paule Wautier, Jean‐Luc Wautier · 2009 · Biorheology
  72. Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects
    Katarı́na Šebeková, Zora Krivošíková, Martin Gajdoš · 2013 · Clinical Chemistry and Laboratory Medicine (CCLM)
  73. Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients
    Wen Hui Peng, Wei Xia Jian, Hai Ling Li, Lei Hou, Yi Dong Wei, Wei Ming Li, Ya Wei Xu · 2011 · Cardiovascular Diabetology
  74. RAGE Gene Polymorphisms Are Associated with Circulating Levels of Endogenous Secretory RAGE but Not with Coronary Artery Disease in Chinese Patients with Type 2 Diabetes Mellitus
    Wen Hui Peng, Lin Lu, Ling Jie Wang, Xiao Xiang Yan, Qiujing Chen, Qi Zhang, Ruiyan Zhang, Wei Feng Shen · 2009 · Archives of Medical Research
  75. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study
    Jonas Malmstedt, Lars Kärvestedt, Jesper Swedenborg, Kerstin Brismar · 2015 · Cardiovascular Diabetology
  76. The Associations of Advanced Glycation End Products and Its Soluble Receptor with Pancreatic Cancer Risk: A Case–Control Study within the Prospective EPIC Cohort
    Verena A. Grote, Alexandra Nieters, Rudolf Kaaks, Anne Marie Tjønneland, Nina Roswall, Kim Overvad, Michael René Skjelbo Nielsen, Françoise Clavel‐Chapelon, Marie‐Christine Boutron‐Ruault, Antoine Racine et al. · 2012 · Cancer Epidemiology Biomarkers & Prevention
  77. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men
    Lydia S. Lamb, Helman S. Alfonso, Paul E. Norman, Timothy M. E. Davis, Josephine Maree Forbes, Gerald Wolfgang Muench, Felix Irrgang, Osvaldo P. Almeida, Jonathan Golledge, Graeme J. Hankey et al. · 2018 · The Journal of Clinical Endocrinology & Metabolism
  78. Effects of Toxic AGEs (TAGE) on Human Health
    Masayoshi Takeuchi, Akiko Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama · 2022 · Cells
  79. Regulated Proteolysis of RAGE and AβPP as Possible Link Between Type 2 Diabetes Mellitus and Alzheimer's Disease
    E. Kojro, R. Postina · 2009 · Journal of Alzheimer's Disease
  80. The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD
    Niki L. Reynaert, Lowie E.G.W. Vanfleteren, Timothy N. Perkins · 2023 · Journal of Clinical Medicine
  81. Complex Tissue-Specific Patterns and Distribution of Multiple RAGE Splice Variants in Different Mammals
    Raquel López‐Díez, Alberto Rastrojo, Olatz Villate, Begoña Aguado · 2013 · Genome Biology and Evolution
  82. Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans
    Ryan K. Perkins, Edwin R. Miranda, Kristian Karstoft, Paul J. Beisswenger, Thomas P. J. Solomon, Jacob M. Haus · 2019 · Nutrients
  83. Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy
    Hala O. Al-Mesallamy, Lamiaa N. Hammad, Tarek A. El Maamoun, Basma M. Khalil · 2010 · Journal of Diabetes and its Complications
  84. Protective Effect of sRAGE on Fetal Development in Pregnant Rats with Gestational Diabetes Mellitus
    Xuwen Tang, Qing-xin Qin, Xiaobin Xie, Ping He · 2014 · Cell Biochemistry and Biophysics
  85. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength [Review]
    Masahiro Yamamoto · 2015 · Endocrine Journal
  86. Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults
    Kathleen E. Davis, Chandan Prasad, Parakat Vijayagopal, Shanil Juma, Victorine Imrhan · 2014 · Nutrition Research
  87. Human soluble receptor for advanced glycation end products and tumor necrosis factor-α as gingival crevicular fluid and serum markers of inflammation in chronic periodontitis and type 2 diabetes
    Sandeep Singhal, A.R. Pradeep, Dharmendra Kanoriya, Vibhuti Garg · 2016 · Journal of Oral Science
  88. 1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease
    Antonino Di Pino, Francesca Urbano, Roberto Scicali, Stefania Di Mauro, Agnese Filippello, Alessandra Scamporrino, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo · 2019 · Cells
  89. FPS-ZM1 Alleviates Neuroinflammation in Focal Cerebral Ischemia Rats via Blocking Ligand/RAGE/DIAPH1 Pathway
    Lingling Shen, Tianyuan Zhang, Yang Yu, Dan Lu, Anding Xu, Keshen Li · 2020 · ACS Chemical Neuroscience
  90. Renal Microvascular Injury in Diabetes: RAGE and Redox Signaling
    Melinda T. Coughlan, Mark Emmanuel Cooper, Josephine Maree Forbes · 2007 · Antioxidants and Redox Signaling
  91. A New Perspective on Therapeutic Inhibition of Advanced Glycation in Diabetic Microvascular Complications: Common Downstream Endpoints Achieved Through Disparate Therapeutic Approaches?
    Karly C. Sourris, Brooke E. Harcourt, Josephine Maree Forbes · 2009 · American Journal of Nephrology
  92. Internalization of the Receptor for Advanced Glycation End Products (RAGE) is Required to Mediate Intracellular Responses
    Natalia Sevillano, María Dolores Girón, Mercedes Salido, Alberto Manuel Vargas, José Vilches, Rafael Salto · 2008 · The Journal of Biochemistry
  93. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients
    Kuang‐Hsing Chiang, Po‐Hsun Huang, Shao‐Sung Huang, Tao-Cheng Wu, Jaw‐Wen Chen, Shing‐Jong Lin · 2009 · Coronary Artery Disease
  94. Comparison of effects of pioglitazone and glimepiride on plasma soluble RAGE and RAGE expression in peripheral mononuclear cells in type 2 diabetes: Randomized controlled trial (PioRAGE)
    Hidenori Koyama, Shinji Tanaka, Masayo Monden, Takuhito Shoji, Tomoaki Morioka, Shinya Fukumoto, Katsuhito Mori, Masanori Emoto, Tetsuo Shoji, Mitsuru Fukui et al. · 2014 · Atherosclerosis
  95. Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products
    Bo Feng, Lei Xu, Hua Wang, Xinfeng Yan, Junli Xue, Fengjing Liu, Ji‐Fan Hu · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  96. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
    Sara Chiappalupi, Laura Salvadori, Aleksandra Vukašinović, Rosario Donato, Guglielmo Sorci, Francesca Riuzzi · 2021 · Life Sciences
  97. Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease
    ZHEN KUN YANG, Ying H. Shen, Wei Feng Shen, Li Jin Pu, Hua Meng, Ruiyan Zhang, Qi Zhang, Qiujing Chen, Raffaele De Caterina, Lin Lu · 2015 · International Journal of Cardiology
  98. Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products
    Makoto Watanabe, Yasuyuki Kawai, Michihiko Kitayama, Hironubu Akao, Atsushi Motoyama, Minoru Wakasa, Ryuhei Saito, Hirofumi Aoki, Kousuke Fujibayashi, Taketsugu Tsuchiya et al. · 2016 · Journal of Cardiology
  99. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms
    Ayman Moawad Mahmoud · 2017 · Advances in experimental medicine and biology
  100. Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study
    Komal Waqas, Jinluan Chen, Fjorda Koromani, Katerina Trajanoska, Bram C. J. van der Eerden, André Gerardus Uitterlinden, Fernando Rivadeneira, M. Carola Zillikens · 2020 · Journal of Bone and Mineral Research